Bharath Takulapalli has over sixteen years of multidisciplinary research experience at the interface of nanotechnology and molecular biology, and is the principal inventor of INanoBio sensor technologies. He has authored multiple publications and patents in the areas of nano sensors, nanotechnology, genome sequencing and protein arrays. With doctoral training in solid state electronics, electrical engineering and molecular sensors, over the past ten years he has worked on developing technology solutions to personalized healthcare of the future. He has adjunct scientist affiliation with The Biodesign Institute at ASU. Dr. Takulapalli has a bachelor’s from IIT Madras India, and PhD from Arizona State University in Tempe.
Follow Bharath on Substack at preemptdisease.substack.com & on Twitter at @PreemptDisease.
GENOME SEQUENCING
Sequencing a person’s genome can identify susceptibility to various diseases, aid in early disease diagnosis, and enable precision medicine – personalization of therapy based on individual specific genomic biomarkers.
CANCER DIAGNOSTICS
Detecting diseases in early stages dramatically improves therapeutic outcomes. In Cancer, average 5 year survival rate is close to 90% when diagnosed at stage 1, and stands at less than 25% when diagnosed at stage 4. In contrast, cost of therapy when diagnosed post metastasis is approximately 2.5 times that when diagnosed at early stages.
